Johnson & Johnson is lowering the recommended top dose of Extra Strength Tylenol to reduce the risk of accidental overdose from acetaminophen.
July 28, 2011 Johnson & Johnson is lowering the maximum recommended dose for Extra Strenth Tylenol to six tablets a day from eight. Too much acetaminophen, the active ingredient in the painkiller, can cause liver damage.
July 27, 2011 A study finds the Medicare drug benefit is trimming around $12 billion in yearly spending on medical care. The savings are not enough to offset the total costs of the program.
July 21, 2011 Some research suggests there may be an increased risk of esophageal cancer for people who take some popular osteoporosis medicines. The Food and Drug Administration is reviewing the data but says there isn't enough information to draw a firm conclusion.
Bottles of antiretroviral drug Truvada, a medicine used in trials that showed a reduction in transmission of HIV between heterosexuals.
Justin Sullivan/Getty Images
July 14, 2011 Results from studies conducted in Africa confirm that drugs against HIV can reduce the risk of transmission of the virus between heterosexual partners. But where and with whom should the approach be used?
July 12, 2011 Last year was the worst ever for drug shortages at the nation's hospitals, according to a nationwide survey. Shortages have led to delays in patient care and made pharmacists scramble to find alternatives.
June 23, 2011 In a 6-3 decision, the court lowered the boom on a Vermont law that requires doctors to agree ahead of time for data on prescriptions they write to be used for marketing by drugmakers. Another decision by the justices protects generic drugmakers from lawsuits.
Does your health insurance cover birth control pills?
June 9, 2011 Three-quarters of Americans favor insurance coverage of birth control pills, including under those policies bought with government assistance, an NPR-Thomson Reuters poll finds. Support is strongest among the young and those with at least a college degree.
Yasmin birth control pills are among those that contain drospirenone, a synthetic hormone that appears to carry an elevated risk for blood clots.
June 2, 2011 A synthetic hormone that was thought to be safer than older ones in the pill is looking riskier. The Food and Drug Administration is looking into data that show an increased risk of blood clots from birth control pills that contain drospirenone.
May 27, 2011 The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.
May 26, 2011 A federal study testing prescription-strength niacin as an add-on to cholesterol-lowering statins to prevent heart disease was stopped early because the niacin did not work. There was also a slight increase in stroke risk for people taking the prescription-strength niacin.
<iframe src="http://www.npr.org/player/embed/136678665/136724412" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
May 26, 2011 Findings from a recent study suggest that if all the HIV-infected people in the world got antiviral drugs, the 30-year-old pandemic could be brought to heel. Now the administration's chief AIDS strategist is leading a what-if discussion about that tack.
Mixing antidepressant Paxil and the cholesterol-fighter Pravachol may lead to an unexpected increase in blood sugar, researchers say.
Joe Raedle/Getty Images
May 25, 2011 Researchers mining reports of adverse drug reaction found a combination of the antidepressant Paxil and cholesterol-fighter Pravachol was associated with a big increase in blood sugar. The unexpected finding suggests that data mining techniques could help detect drug interactions.
May 19, 2011 Patents are expiring on medicines launched during the 1990s, triggering a wave of new generic drugs. These days most prescriptions are filled with generics, which can save consumers on copays or the amount those without insurance have to pay out of their own pocket.
<iframe src="http://www.npr.org/player/embed/136469996/136475110" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
May 13, 2011 Securities filings by Google and Johnson & Johnson earlier this week revealed details about government probes related to the marketing of prescription drugs. Settlements of the allegations are said to be near.
May 10, 2011 The federal government alleged that Lauren Stevens, once an in-house lawyer, had obstructed an Food and Drug Administration investigation into Glaxo's marketing of the antidepressant Wellbutrin as a weight-loss aid. A federal judge acquitted her before the defense called a witness.
NPR thanks our sponsors
Become an NPR sponsor